Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Prism Medico & Pharmacy's Pretax Margin % or its related term are showing as below:
BOM:512217'
s Pretax Margin % Range Over the Past 10 Years
Min: -10.41 Med: -1.01 Max: 17.58
Current: 17.58
BOM:512217's Pretax Margin % is ranked better than 87.78% of 1956
companies
in the Consumer Packaged Goods industry
Industry Median: 4.68
vs BOM:512217: 17.58
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Prism Medico & Pharmacy Pretax Margin % Related Terms
Prism Medico & Pharmacy Pretax Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:512217 vs ADM, BG, TSN: Pretax Margin % Comparison
For the Farm Products subindustry, Prism Medico & Pharmacy's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Prism Medico & Pharmacy Pretax Margin % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Prism Medico & Pharmacy's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Prism Medico & Pharmacy's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Prism Medico & Pharmacy (BOM:512217) has a Pretax Margin % of -43.67% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Prism Medico & Pharmacy and its competitors. According to the industry distribution chart, Prism Medico & Pharmacy ranks #239 out of 1956 companies in the Consumer Packaged Goods industry, placing it in the top 12.2%.
Is Prism Medico & Pharmacy's Pretax Margin % too high?
Prism Medico & Pharmacy's current Pretax Margin % is -43.67%. Based on the distribution chart, Prism Medico & Pharmacy ranks #239 out of 1956 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Prism Medico & Pharmacy has a GF Score™ of 54/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Prism Medico & Pharmacy's Pretax Margin % compare to ADM and BG?
According to the Consumer Packaged Goods industry distribution chart, Prism Medico & Pharmacy ranks #239 out of 1956 companies for Pretax Margin %. This places Prism Medico & Pharmacy in the top 12% of its industry — outperforming the majority of peers. The industry median Pretax Margin % is 4.68. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Consumer Packaged Goods company?
The median Pretax Margin % among Consumer Packaged Goods companies is 4.68, based on 1,956 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Prism Medico & Pharmacy and its competitors. For the Consumer Packaged Goods industry, the median Pretax Margin % is 4.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Prism Medico & Pharmacy's current Pretax Margin % is -43.67%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Prism Medico & Pharmacy stock overvalued right now?
Based on GuruFocus' analysis, Prism Medico & Pharmacy (BOM:512217) is currently considered Fairly Valued. The stock's GF Value™ is ₹27.55, compared to a current price of ₹27.70 — trading 0.5% above its estimated fair value. The current Pretax Margin % is -43.67%. Prism Medico & Pharmacy's overall GF Score™ is 54/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Prism Medico & Pharmacy (BOM:512217), the current Pretax Margin % is -43.67% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Prism Medico & Pharmacy (BOM:512217) Overvalued in 2026?
Based on GuruFocus' analysis, Prism Medico & Pharmacy stock appears to be overvalued.
The current stock price of ₹27.70 is trading 0.5% above its estimated GF Value™ of ₹27.55.
GuruFocus considers Prism Medico & Pharmacy to be Fairly Valued.
Key valuation signals for BOM:512217:
Pretax Margin %: -43.67%
GF Value™: ₹27.55 vs. price of ₹27.70 (0.5% above fair value)
No single metric tells the full story. See the BOM:512217 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Prism Medico & Pharmacy Ltd operates in the wholesale and retail of animal feed, poultry feed, cattle feed, aqua feed, ayurvedic foods, organic food, juices, cosmetics, herbal extracts, nutrients, and FMCG products. The company generates the majority of its revenue from the sale of agricultural products.
54GF Score
Get the complete analysis for BOM:512217
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:512217 has been successfully added to your 
